documents: FDA-1977-N-0013-0032
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1977-N-0013-0032 | FDA | FDA-1977-N-0013 | Reference 56 - Eastern Research Group, Inc. "Cost Benefit Analysis of Proposed FDA Rule on Overthe-Counter Internal Analgesic, Antipyretic, and Antirheumatic Drug Products; Required Warnings," Final Report, October 6, 2004, with Addendum, July 30, 2007. re: Background Material from FDA (Part 2 of Reference 56) | Supporting & Related Material | Background Material | 2009-04-29T04:00:00Z | 2009 | 4 | 2019-02-06T14:05:23Z | 0 | 0 | 0900006480829234 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref